1. Home
  2. KMT vs NVCR Comparison

KMT vs NVCR Comparison

Compare KMT & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kennametal Inc.

KMT

Kennametal Inc.

HOLD

Current Price

$28.55

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$12.63

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMT
NVCR
Founded
1938
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
KMT
NVCR
Price
$28.55
$12.63
Analyst Decision
Hold
Buy
Analyst Count
5
6
Target Price
$24.60
$28.42
AVG Volume (30 Days)
804.7K
1.8M
Earning Date
02-04-2026
10-30-2025
Dividend Yield
2.81%
N/A
EPS Growth
N/A
N/A
EPS
1.22
N/A
Revenue
$1,982,871,000.00
$642,269,000.00
Revenue This Year
$7.69
$9.75
Revenue Next Year
$3.82
$5.62
P/E Ratio
$23.35
N/A
Revenue Growth
N/A
11.17
52 Week Low
$17.30
$10.70
52 Week High
$29.89
$34.13

Technical Indicators

Market Signals
Indicator
KMT
NVCR
Relative Strength Index (RSI) 61.52 51.80
Support Level $28.39 $12.30
Resistance Level $29.89 $13.94
Average True Range (ATR) 0.57 0.66
MACD -0.11 0.07
Stochastic Oscillator 48.70 58.41

Price Performance

Historical Comparison
KMT
NVCR

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: